Article
HLA-DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis.
Arthritis care & research - 1 Oct 2023
Lerman Alison M, Mahmud Shawn A, Alfath Zineb, Langworthy Benjamin W, Hobday Patricia M, Riskalla Mona M, Binstadt Bryce A
Abstract excerpt
OBJECTIVE: Concern exists that medications used to treat patients with systemic juvenile idiopathic arthritis (JIA), particularly interleukin (IL)-1 and IL-6 blocking agents, might be causing adverse drug reactions and lung disease (systemic JIA-LD). Carriage of HLA-DRB1*15 has been reported as a risk factor for adverse drug reactions among patients with systemic JIA. We performed a retrospective chart review to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
